Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 26, 2023 08:00 ET | Source: electroCore, Inc.

electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology

ROCKAWAY, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...
September 25, 2023 08:00 ET | Source: electroCore, Inc.

electroCore to Participate in the LD Micro Main Event XVI Conference

ROCKAWAY, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
September 21, 2023 08:00 ET | Source: electroCore, Inc.

electroCore to Present at iAccess Alpha’s – Top 10 Best Ideas from the Buyside Virtual Conference

ROCKAWAY, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
September 07, 2023 08:00 ET | Source: electroCore, Inc.

electroCore to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

ROCKAWAY, N.J., Sept. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
July 18, 2023 08:00 ET | Source: electroCore, Inc.

electroCore Expands Intellectual Patent Portfolio for nVNS Technology

ROCKAWAY, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...
July 13, 2023 08:00 ET | Source: electroCore, Inc.

electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC

ROCKAWAY, N.J., July 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that ReletexTM by Reliefband,...
July 11, 2023 08:00 ET | Source: electroCore, Inc.

electroCore Provides Select Second Quarter 2023 Financial Guidance

ROCKAWAY, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today provided select preliminary...
June 27, 2023 08:00 ET | Source: electroCore, Inc.

TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project

ROCKAWAY, N.J., June 27, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that its TAC-STIM non-invasive...
June 14, 2023 08:00 ET | Source: electroCore, Inc.

electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC

ROCKAWAY, N.J., June 14, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger,...
June 13, 2023 08:00 ET | Source: electroCore, Inc.

electroCore Announces Poster to be Presented at the American Headache Society’s 65th Annual Scientific Meeting

ROCKAWAY, N.J., June 13, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that “SUNCT/ SUNA with...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right